IQVIA (IQV)
IQVIA stock today
IQVIA closed at $267.33 on October 30, 2026, down 2.81% on the day. Over the past year it returned +23.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $44.0 billion.
| Period | IQV | S&P 500 (SPY) |
|---|---|---|
| 1 month | -0.6% | -0.9% |
| 3 months | +12.4% | +2.1% |
| Year to date | +18.6% | +11.7% |
| 1 year | +23.5% | +12.4% |
| 3 years | +50.9% | +88.5% |
| 5 years | +2.3% | +76.0% |
Key statistics
- Market value
- $44.0B
- P/E (trailing)
- 32.6
- Forward P/E
- 19.2
- Price / sales
- 2.5
- 52-week range
- $156.66 to $279.36
About IQVIA
Provides research, technology, and consulting services to pharmaceutical and life sciences companies.
Sector: Health Care · Industry: Life Sciences Tools & Services
More on IQVIA
- Financials: revenue, earnings and segmentsRevenue +6% in the year to Dec 2025
- Valuation: P/E history and peersP/E 32.6, median 35.8 at its last 9 year ends
- Returns: what $1,000 became$1,000 ten years ago is $3,725 today
No forecast, no recommendation. This page describes IQVIA from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.